CONMED Corp Files 8-K on Financials
Ticker: CNMD · Form: 8-K · Filed: Jul 31, 2024 · CIK: 816956
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: CNMD
TL;DR
CONMED filed an 8-K detailing financial results and exhibits as of July 31, 2024.
AI Summary
CONMED Corporation filed an 8-K on July 31, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial performance and includes relevant exhibits for the period ending July 31, 2024. CONMED Corporation is incorporated in Delaware and headquartered in Largo, Florida.
Why It Matters
This 8-K filing provides investors with crucial updates on CONMED Corporation's financial health and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any unusual risks or events.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- July 31, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Largo, Florida (location) — Address of principal executive offices
FAQ
What specific financial information is being reported in this 8-K filing?
This 8-K filing reports on CONMED Corporation's Results of Operations and Financial Condition, and includes Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is July 31, 2024.
In which state is CONMED Corporation incorporated?
CONMED Corporation is incorporated in Delaware.
What is the principal executive office address for CONMED Corporation?
The principal executive office address is 11311 Concept Blvd, Largo, Florida 33773.
What is the telephone number for CONMED Corporation?
The telephone number for CONMED Corporation is (727) 392-6464.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-07-31 16:19:56
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by che
Filing Documents
- form8k-32663_cnmd.htm (8-K) — 24KB
- ex99-1.htm (EX-99.1) — 258KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001174947-24-000936.txt ( ) — 473KB
- cnmd-20240731.xsd (EX-101.SCH) — 3KB
- cnmd-20240731_lab.xml (EX-101.LAB) — 33KB
- cnmd-20240731_pre.xml (EX-101.PRE) — 22KB
- form8k-32663_cnmd_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On July 31, 2024, CONMED Corporation issued a press release announcing financial results for the second quarter ended June 30, 2024. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K that is furnished under "Item 2.02. Results of Operations and Financial Condition" and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are included herewith: Exhibit No. Description of Exhibit 99.1 Press Release dated July 31, 2024, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 31, 2024 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance and Chief Financial Officer